NDC11 63323010213
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0102-13 | 63323-0102 |
| 63323-102-13 | 63323-102 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | c550dd16-a5e8-44be-87f2-210c15bbb513 | 2024-10-14 | Warnings, Adverse reactions | 63323-102-13 63323-102 63323010213 |
| GEMCITABINE | GEMCITABINE | Fresenius Kabi USA, LLC | d1f3951c-d13f-4662-ad4b-ecfc07f59104 | 2021-01-20 | Warnings, Adverse reactions | 63323-102 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.